EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Pediatric dermatophyte onychomycosis: a review

Aditya K Gupta iD, Daniel Taylor

International Journal of Dermatology · 2025-03 · 64 (3) · 465-472

DOI: 10.1111/ijd.17495 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Dermatology, online erschienen am 18.09.2024. Verfasst von Aditya K Gupta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Onychomycosis, Antifungal Agents, Foot Dermatoses. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have reported an increase in pediatric onychomycosis prevalence worldwide, suggesting that this population may be increasingly affected by the infection. A summary of the epidemiological impact, antifungal treatment options, special considerations for at‐risk subpopulations, and methods to prevent infection and recurrence are discussed. A systematic review of available epidemiological studies found the worldwide prevalence of culture‐confirmed pediatric toenail onychomycosis to be 0.33%, with no significant increases in prevalence over time. A systematic review of studies investigating the efficacy of various antifungals in treating pediatric onychomycosis found high cure rates and low frequency of adverse events with systemic itraconazole and terbinafine; however, the studies are few, dated, and lack impact because of small sample sizes. Comparatively, clinical trials implementing FDA‐approved topical antifungal treatments report slightly reduced cure rates with larger sample sizes. Patients with immunity‐altering conditions, such as Down's syndrome, or those immunosuppressed because of chemotherapy or HIV/AIDS are at a greater risk of onychomycosis infection and require special consideration with treatment. Proper sanitization and hygiene practices are necessary to reduce the risk of acquiring infection. Early diagnosis and treatment of onychomycosis in children, as well as any affected close contacts, are crucial in reducing the impact of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OnychomycosisAntifungal AgentsFoot DermatosesHumansChildPrevalenceTerbinafineItraconazoleImmunocompromised Host

Stichwörter der Autor:innen

childrenonychomycosispediatricprevalencepreventiontinea unguiumtreatment

Substanzen

Antifungal AgentsTerbinafineItraconazole

Autor:innen und Institutionen

  • Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Mediprobe Research Inc., London, ON, Canada.

ORCID-Profile: Aditya K Gupta

Zitieren

APA

Gupta, A. K., & Taylor, D. (2025). Pediatric dermatophyte onychomycosis: a review. International Journal of Dermatology, 64(3), 465-472. https://doi.org/10.1111/ijd.17495

Vancouver

Gupta AK, Taylor D. Pediatric dermatophyte onychomycosis: a review. International Journal of Dermatology. 2025;64(3):465-472. doi:10.1111/ijd.17495

BibTeX
@article{Gupta2025,
  author = {Gupta, Aditya K and Taylor, Daniel},
  title = {Pediatric dermatophyte onychomycosis: a review},
  journal = {International Journal of Dermatology},
  year = {2025},
  volume = {64},
  number = {3},
  pages = {465--472},
  doi = {10.1111/ijd.17495}
}
Kostenlos starten →